Adult vs. Embryonic
Scientifically, somatic cell nuclear transfer has not produced a single cure, whereas adult stem cell research has produced verifiable therapeutic benefits results.
In a commentary by Toni Meyer, in the Home News Tribune (a central New Jersey daily newspaper) published Dec. 21, 2004, she states “Adult stem cells have already successfully treated spinal-cord injuries, leukemia, and even Parkinson’s disease. They are derived from umbilical cords, placentas, amniotic fluid, various tissues and organ systems like skin and the liver, and even fat obtained from liposuction.”
The successful use of adult stem cells in treatment of disease stands in sharp contrast to the lack of success of embryonic stem cells.
Diseases in which adult stem cells have been successfully used in humans:
1. Brain Cancer
2. Retinoblastoma
3. Ovarian Cancer
4. Merkel Cell Cancer
5. Testicular Cancer
6. Lymphoma
7. Acute Lymphobolastic Leukemia
8. Acute Myelogenous Leukemia
9. Chronic Myelogenous Leukemia
10. Juvenile Myelomonocytic Leukemia
11. Angioimmunoblastic Lympha-denopathy with Dysproteinemia
12. Multiple Myeloma
13. Myelodysplasia
14. Breast Cancer
15. Neuroblastoma
16. Non-Hodgkin’s Lymphoma
17. Hodgkin’s Lymphoma
18. Renal Cell Carcinoma
19. Various Solid Tumors
20. Soft Tissue Sarcoma
21. Scleromyxedema
22. Multiple Sclerosis
23. Crohn’s Disease
24. Rheumatoid Arthritis
25. Juvenile Arthritis
26. Systemic Lupus
27. Polychondritis
28. Systemic Vasculitis
29. Sjogren’s Syndrome
30. Behcet’s Disease
31. Myasthenia
32. Red Cell Aplasia
33. Autoimmune Cytopenia
34. X-Linked Lymphoproliferative Syndrome
35. X-Linked Hyperimmunoglobuline-M Syndrome
36. Severe Combined Immunodeficiency Syndrome-X1
37. Sickle Cell Anemia
38. Sideroblastic Anemia
39. Waldenstrom’s Macroglobulinemia
40. Aplastic Anemia
41. Amegakaryocytic Thrombocytopenia
42. Chronic Epstein-Barr Infection
43. Fanconi’s Anemia
44. Diamond Blackfan Anemia
45. Thalassemia
46. Stroke
47. Osteogenesis Imperfecta
48. Sandhoff Disease
49. Corneal Regeneration
50. Hemophagocytic Lymphohistiocytosis
51. Primary Amyloidosis
52. Limb Gangrene
53. Surface Wound Healing
54. Heart Damage
55. Parkinson’s Disease
56. Spinal Cord Injury
The Economic Issue
Many biotech firms argue that embryonic stem cell research is important for the economic benefits it may bring to the community. Successful business ventures ordinarily bring economic benefit to a community. However “successful” is not synonymous with “ethical” - especially when science and medicine are concerned.
The Center for Bioethics and Human Dignity (http://www.cbhd.org) states “that doing research on embryonic parts is good science. But so is taking random people in the population, giving them a deadly disease, and watching the progression. There are certain things we just don’t do because they undermine our society and assault our humanity. “
“During the annual ‘Berlin Speech’ on May 18th, 2001, German President Johannes Rau spoke ardently in defense of human dignity and against the subjection of human life to economic interests saying, ‘Surely we can agree that an ethically unjustifiable act does not become allowable simply by promising economic benefit.’ If economics begin determining our ethics, if money is our ruler for how we treat our neighbor, we will slowly begin to cannibalize ourselves. The only protection from harm will become wealth and power.”
The Center observes “The potential for economic benefit has become the impetus for building coalitions that are defying ideological divisions and party politics. Free-market capitalists and investors have joined with patient advocates and scientists to favor an unrestrained biotech future. The recent German Parliament debate on bioethics is just one illustration of the political upheaval that biotechnology is generating. Many worry about being left behind in the biotechnological revolution. But willingness to make economic criteria primary in social ethics, as German Chancellor Gerard Schroder recently suggested, undermines the very social structures that support that economic system.” |